首页 | 本学科首页   官方微博 | 高级检索  
检索        

丹参酮ⅡA抑制HepG2细胞生长及诱导其凋亡的实验研究
引用本文:钟志宏,陈文贵,柳永和,李启星,邱月.丹参酮ⅡA抑制HepG2细胞生长及诱导其凋亡的实验研究[J].中南大学学报(医学版),2007,32(1):99-103.
作者姓名:钟志宏  陈文贵  柳永和  李启星  邱月
作者单位:1.湖南师范大学医学院,长沙 410006; 2.湘雅医学院情报与信息技术学院, 长沙 410078
基金项目:湖南师范大学校科研和教改项目
摘    要:目的:研究丹参酮ⅡA对人肝癌细胞HepG2的生长抑制作用和凋亡诱导作用.方法:以0μg/mL丹参酮ⅡA作阴性对照,MTT法检测0.5~10.0 μg/mL丹参酮ⅡA作用人肝癌细胞HepG2 24,48,72 h的生长抑制率;HT33258荧光染色、琼脂糖凝胶电泳、流式细胞仪检测不同浓度丹参酮ⅡA作用HepG2细胞72 h后的细胞凋亡.结果:0.5~10.0 μg/mL丹参酮ⅡA均能抑制人肝癌细胞HepG2生长,并有明显的时间和剂量依赖性;在24,48,72 h的半数抑制浓度分别为14.7,7.4,3.9 μg/mL;经丹参酮ⅡA作用后,荧光染色可以观察到典型的凋亡细胞形态特征;琼脂糖凝胶电泳结果显示除1.0 μg/mL组外均可见明显的凋亡细胞形成的梯状条带;流式细胞仪检测不同浓度丹参酮ⅡA作用72 h后的细胞凋亡率分别为20.32%±2.16%,28.01%±2.35%,33.87%±3.43%,46.73%±4.08%和57.85%±3.74%,与对照组比较差异均有统计学意义(P<0.05).结论:丹参酮ⅡA在体外能明显抑制人肝癌细胞HepG2生长,抑制其生长的机制可能是诱导细胞凋亡.

关 键 词:丹参酮ⅡA  恶性肿瘤  肝癌  HepG2细胞  细胞凋亡  
文章编号:1672-7347(2007)01-0099-05
收稿时间:2006-01-11
修稿时间:2006年1月11日

Inhibition of cell growth and induction of apoptosis in human hepatoma cell line HepG2 by tanshione Ⅱ A
ZHONG Zhi-hong,CHEN Wen-gui,LIU Yong-he,LI Qi-xing,QIU Yue.Inhibition of cell growth and induction of apoptosis in human hepatoma cell line HepG2 by tanshione Ⅱ A[J].Journal of Central South University (Medical Sciences)Journal of Central South University (Medical Sciences),2007,32(1):99-103.
Authors:ZHONG Zhi-hong  CHEN Wen-gui  LIU Yong-he  LI Qi-xing  QIU Yue
Institution:1.Medical School of Hunan Normal University, Changsha 410006; 2.School of Medical Technology and
Information,Central South University,Changsha 410078,China
Abstract:OBJECTIVE: To determine the effect of tanshinone IIA on the growth and apoptosis in human hepatoma cell line HepG2. METHODS: The human hepatoma cell line HepG2 was treated with tanshinone IIA at various concentrations for 72 h. The inhibition of proliferation was measured by MTT assay and apoptosis-related alterations in morphology measured by cytochemical staining (HT33258). DNA fragmentation was evaluated by agarose gel electrophoresis. Apoptotic rate and cell arrest were quantified by flow cytometry (FCM). RESULTS: Tanshinone IIA inhibited the growth of HepG2 in a time- and dose- dependent manner. The semi-inhibitory concentration (IC50) value after the treatment with tanshinone IIA on HepG2 for 24, 48 and 72 h were 14.7, 7.4, and 3.9 microg/ mL, respectively. After the treatment with 0.5 - 10 microg/mL tanshinone IIA for 72 h, the formation of apoptotic bodies was observed. DNA ladder was shown in agarose gel electrophoresis, in addition to the cells treated by 1.0 microg/mL tanshinone IIA . The apoptotic rates at 0.5, 1.0, 2.0, 5.0, and 10.0 microg/mL for 72 h were 20.32%+/-2.16%, 28.0%+/-2.35%, 33.87%+/-3.43%, 46.73%+/-4.08% and 57.85%+/-3.74%, respectively, which were all significantly higher than those of the control group (P<0.05). CONCLUSION: Tanshinone IIA can inhibit the proliferation of human hepatoma cell line HepG2 in a time- and dose- dependent manner, and the mechanism of growth inhibition of human hepatoma cells may be related to the induction of apoptosis.
Keywords:tanshinone ⅡA  manignant tumor  liver tumor  HepG2  cell apoptosis
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中南大学学报(医学版)》浏览原始摘要信息
点击此处可从《中南大学学报(医学版)》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号